Viking Therapeutics (VKTX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to $7.8 million.
- Viking Therapeutics' Interest & Investment Income fell 3259.91% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 778.98%. This contributed to the annual value of $40.9 million for FY2024, which is 17256.99% up from last year.
- Latest data reveals that Viking Therapeutics reported Interest & Investment Income of $7.8 million as of Q3 2025, which was down 3259.91% from $9.0 million recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Interest & Investment Income registered a high of $11.8 million during Q2 2024, and its lowest value of $125000.0 during Q3 2021.
- In the last 5 years, Viking Therapeutics' Interest & Investment Income had a median value of $4.5 million in 2023 and averaged $4.5 million.
- Per our database at Business Quant, Viking Therapeutics' Interest & Investment Income plummeted by 8259.62% in 2021 and then skyrocketed by 169723.32% in 2023.
- Viking Therapeutics' Interest & Investment Income (Quarter) stood at $159000.0 in 2021, then soared by 360.38% to $732000.0 in 2022, then soared by 542.9% to $4.7 million in 2023, then skyrocketed by 130.43% to $10.8 million in 2024, then fell by 28.33% to $7.8 million in 2025.
- Its Interest & Investment Income was $7.8 million in Q3 2025, compared to $9.0 million in Q2 2025 and $9.9 million in Q1 2025.